Canadian law firm Davis LLP has strengthened its life sciences department with the addition of Sara Zborovski as partner.
Zborovski assists companies in navigating the regulatory landscape imposed by the Food and Drugs Act and advocates before all branches of Health Canada on behalf of the food and beverage, pharmaceutical, medical device and cosmetic industries.
Rob Seidel, QC, managing partner at Davis, said adding Zborovski to its team would “bring further depth and breadth” to the firm.
"Our clients will benefit from Sara's background and extensive experience acting on matters related to Health Canada issues, as well as her understanding of the regulatory and commercial environment in which they operate," Seidel said.
Davis recently made further additions to its IP and life sciences capabilities with the hiring of Andy Radhakant, Julian Worsley and Neil Fineberg as partners.
Davis LLP is a full-service national law firm with more than 250 lawyers across Canada and in Tokyo, Japan.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at firstname.lastname@example.org
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
life sciences, pharmaceutical, medical, Food and Drugs Act,